Breast Cancer: Treatment or Not? HFE 742 Cathy Simmons November 10, 2005.

Slides:



Advertisements
Similar presentations
Preventing Cancer with Healthy Life Styles Li-Fen L. Chang, M.D., Ph.D. Radiation Oncology SOMC Cancer Center.
Advertisements

National Institute of Oncology Rabat-Morocco. National Institute of Oncology I.N.O. Rabat, Morocco : New Cases.
Translational Cancer Research From Laboratory to Practice William J Catalona MD Professor of Urology Director, Clinical Prostate Cancer Program Northwestern.
Professor of Hematology, Oncology, Medicine and Epidemiology
An Introduction to Cancer Biology Geoff Mitchell April 24, 2007.
Breast Cancer Research Presented by Manish Modi Manish Modi Stevens Institute of Technology REU SUMMER 2005.
BMP receptor1a Amit Patel Estimated US Cancer Deaths* ONS=Other nervous system. Source: American Cancer Society, Men 295,280 Women 275,000.
Cancer Dr. Raid Jastania. Cancer In the US: 1.3 million new cancer cases in 2002 >500,000 death of cancer Increase cancer death in men due to lung cancer.
April 6, o What is cancer? o Cancer statistics o Cancer prevention and early detection o Cancer disparities o Cancer survivorship o Cancer research.
Tuesday, June 23, Today’s discussion General cancer statistics Cancer in Canada PEI Statistics at a glance Impact.
1 Cancer PREVENTION “Take charge of your life and learn as much as you can about illness. Knowledge generates hope.” Lance Armstrong Winner of 6 Tour de.
Dietary intakes of calcium and vitamin D and risk of colorectal cancer in women Jennifer Lin, PhD Division of Preventive Medicine Brigham and Women’s Hospital.
BREAST CANCER AWARENESS OCTOBER IS THE MONTH THIS IS INFO ABOUT GLOBAL USA MASSACHUSETTS and its COUNTIES.
Cancer and Minorities Norma Kanarek, MPH, PhD Department of Environmental Health Sciences, Johns Hopkins Bloomberg School of Public Health Department of.
Cervical Cancer. Cervix Lower part of the uterus Lower part of the uterus Connects the body of the uterus to the vagina (birth canal) Connects the body.
* For those free of cancer at beginning of age interval. Source: DevCan: Probability of Developing or Dying of Cancer Software, Version Statistical.
An Introduction to Cancer. 1.Heart Diseases685, Cancer556, Cerebrovascular diseases157, Chronic lower respiratory diseases126,382.
Advances in Nuclear Medicine and its Impact on Diagnosis and Management of GI Cancers Medhat Osman, MD PhD Philip Alderson, MD.
The Process of Cell Growth & Division. 1. How is the life cycle of a human and a single cell similar? 1. How is the life cycle of a human and a single.
MOLLY SCHWENN, MD CANCER REGISTRY MAINE CDC, DHHS OCTOBER 25, 2013 Population-based Cancer Surveillance: State Perspective.
Health Report on Cancer Bryan Gregory (Extra Credit Presentation)
Epidemiology of Oral Cancer Module 1:. Epidemiology of Cancer, U.S.
Cell Culture Forensics. S. O’brien PNAS July 3, 2001 vol. 98 no Henrietta Lacks Cancer: Detection and Treatment.
* For those free of cancer at beginning of age interval. Source: DevCan: Probability of Developing or Dying of Cancer Software, Version Statistical.
BIOE 301 Lecture Twelve Jair Martinez Bioengineering Department Rice University.
Cancer Incidence and Mortality in Massachusetts, Bureau of Health Statistics, Research and Evaluation Massachusetts Department of Public Health.
Cancer Staging.
Cancer Among Native Americans in Arizona and New Mexico Data Provided by Arizona Cancer Registry at the Arizona Department of Health Services and the New.
Cell Cycle Regulation and Cancer. 3 Checkpoints Control the cell cycle (inspection points) Make sure the cell is ready to move into the next phase. Mitosis.
US Cancer Burden Epi 242 Cancer Epidemiology Binh Goldstein, Ph.D. October 7, 2009.
Cancer. What is Cancer? – –Cancer develops when cells in a part of the body begin to grow out of control. Although there are many kinds of cancer, they.
Regulating the Cell Cycle Biology 392 Chapter 10-3.
Colon Cancer Chris Aresco Statistics 51,848 people in the United States died of colon cancer in 2009 (26,806 men and 25,042 women) Colon cancer is not.
Prostate Cancer Treatment: What’s Best For You?
WE WILL ALL DIE OF CANCER If something else doesn’t kill us first HYPOTHESIS:
HEAD/NECK OF THE SKIN ANALYTIC vs. NON-ANALYTIC by YEAR N = 1800.
RankCause of DeathNumberDeath Rate % of Deaths All causes2,543, % 1Diseases of the heart 599, Malignant neoplasms 582,
RCS 6080 Medical and Psychosocial Aspects of Rehabilitation Counseling Cancer.
Regulating the Cell Cycle
Role of the Surgeon in Cancer Management A. Responsible for the initial diagnosis and management of solid tumors. B. Responsible for the Definitive Surgical.
Cell Culture Forensics. S. O’brien PNAS July 3, 2001 vol. 98 no Henrietta Lacks Cancer: Causes and Treatment.
Cancer as a genetic chapter 21 pp & lecture notes.
THE CELL CYCLE AND CANCER. OK…what tells a cell when to divide (or, indeed, when NOT to divide)?
THE CELL CYCLE AND CANCER. Control of the Cell cycle Control of the cell cycle.
DL Wickerham MD Deputy Chairman NRG Oncology Oct 5, 2015
Tools to Access the Latest Cancer Statistics Paul Miller Washington Reporting Fellowships program presentation April 15, 2013.
BME 301 Lecture Twelve.
Prostate Cancer Outcomes by Race & Treatment Site Can-lan Sun MD PhD, Smita Bhatia MD MPH, Lennie Wong PhD, Gail Washington DNS, Karen Nielsen-Menicucci.
The Genetic Component of a Common Disease The Paradigm of Cancer Genetics John Quillin, PhD, MPH, MS Virginia Commonwealth University Fall, 2005.
The Genetic Component of a Common Disease The Paradigm of Cancer Genetics John Quillin, PhD, MPH, MS Virginia Commonwealth University Summer, 2006.
Cell Culture Forensics. S. O’brien PNAS July 3, 2001 vol. 98 no Henrietta Lacks Cancer: Detection and Treatment.
Bioengineering and World Health Lecture Twelve. Four Questions What are the major health problems worldwide? Who pays to solve problems in health care?
Homework #3 is due 11/19 Bonus #2 is posted. Cancer: is the loss of control over cell division. Tumors are normal cells that are dividing inappropriately.
Cell Cycle Regulation and Cancer. 3 Checkpoints Control the cell cycle (inspection points) Make sure the cell is ready to move into the next phase. Mitosis.
Riva L. Rahl, M.D. Cooper Clinic Preventive Medicine Physician Medical Director, Cooper Wellness Program Cancer: Beating the Odds.
Cancer: causes abnormal and uncontrolled cell growth to occur within body Because cancer cells continue to grow and divide, they are different from normal.
Cell Division Mitosis. Why do they have to be so small? Why not keep growing – why divide? Surface area to Volume ratio Too much volume, too little space.
Premature deaths due to Prostate Cancer: The Role of Diagnosis and Treatment Appathurai Balamurugan MD, MPH S William Ross MD Chris Fisher, BS Jim Files,
Quality of Life after Prostate Cancer Treatment: Trajectories of Recovery using Piecewise Latent Growth Curve Analyses Michael A. Diefenbach, Ph.D., Icahn.
Age-adjusted death rates by type of cancer by race, Kansas City, Missouri, Death rateDisparity ratio Causes of cancer 2020 objectiveAllWhiteBlackWhiteBlack.
What is cancer?. Cancer Development of abnormal cells Divide uncontrollably Can infiltrate and destroy normal body tissue.
US Mortality, 2003 No. of deaths % of all deaths Rank Cause of Death
Non-Communicable Diseases Lesson 7
Cancer Epidemiology Kara P. Wiseman, MPH, Phd
Estimated current cancer incidence
Presentation transcript:

Breast Cancer: Treatment or Not? HFE 742 Cathy Simmons November 10, 2005

PLAN  Background  Stages of breast cancer  Influence diagram  Treatments for stages – ”influence diagrams”  Decision tree  The DECISION

Background  Personal reasons  Death of father  Incident in paternal grandfather  Death of mother-in-law  Statistics  Mortality rates  Incidence rates

US Mortality, 2002 Source: US Mortality Public Use Data Tape 2002, National Center for Health Statistics, Centers for Disease Control and Prevention, Heart Diseases696, Cancer557, Cerebrovascular diseases162, Chronic lower respiratory diseases124, Accidents (Unintentional injuries)106, Diabetes mellitus73, Influenza and pneumonia65, Alzheimer disease58, Nephritis40, Septicemia33, RankCause of Death No. of deaths % of all deaths

2005 Estimated US Cancer Deaths* ONS=Other nervous system. Source: American Cancer Society, Men 295,280 Women 275,000 27%Lung and bronchus 15%Breast 10%Colon and rectum 6%Ovary 6%Ovary 6%Pancreas 6%Pancreas 4%Leukemia 4%Leukemia 3%Non-Hodgkin lymphoma 3%Non-Hodgkin lymphoma 3%Uterine corpus 3%Uterine corpus 2%Multiple myeloma 2%Multiple myeloma 2%Brain/ONS 2%Brain/ONS 22% All other sites Lung and bronchus31% Prostate10% Colon and rectum10% Pancreas5% Leukemia4% Esophagus4% Liver and intrahepatic3% bile duct Non-Hodgkin 3% Lymphoma Urinary bladder3% Kidney3% All other sites 24%

2005 Estimated US Cancer Cases* *Excludes basal and squamous cell skin cancers and in situ carcinomas except urinary bladder. Source: American Cancer Society, Men 710,040 Women 662,870 32%Breast 12%Lung and bronchus 11%Colon and rectum 6%Uterine corpus 4%Non-Hodgkin lymphoma 4%Non-Hodgkin lymphoma 4%Melanoma of skin 3% Ovary 3% Ovary 3%Thyroid 3%Thyroid 2%Urinary bladder 2%Pancreas 21%All Other Sites Prostate33% Lung and bronchus13% Colon and rectum10% Urinary bladder7% Melanoma of skin5% Non-Hodgkin4% lymphoma Kidney3% Leukemia3% Oral Cavity3% Pancreas2% All Other Sites17%

Cancer Death Rates*, for Women, US, *Age-adjusted to the 2000 US standard population. Source: US Mortality Public Use Data Tapes , US Mortality Volumes , National Center for Health Statistics, Centers for Disease Control and Prevention, Lung & bronchus Colon & rectum Uterus Stomach Breast Ovary Pancreas Rate Per 100,000 Breast cancer has consistently been a leading cause of cancer deaths since 1930.

Age Specific Incidence & Death Rates for Women with Breast Cancer, by race, US, Source: Incidence – Surveillance, Epidemiology, and End Results Program, , Division of Cancer Control and Population Science, National Cancer Institute, Deaths – National Center for Health Statistics, Centers for disease Control and Prevention, 2005.

Lifetime Probability of Developing Cancer, By Site, Women, US, Source:DevCan: Probability of Developing or Dying of Cancer Software, Version 5.2 Statistical Research and Applications Branch, NCI, SiteRisk All sites 1 in 3 Breast 1 in 7 Lung & bronchus 1 in 18 Colon & rectum 1 in 18 Uterine corpus 1 in 38 Non-Hodgkin lymphoma 1 in 56 Ovary 1 in 68 Melanoma 1 in 78 Pancreas 1 in 81 Urinary bladder 1 in 88 Uterine cervix 1 in 130

Cancer Survival*(%) by Site and Race, *5-year relative survival rates based on cancer patients diagnosed from 1995 to 2000 and followed through Source: Surveillance, Epidemiology, and End Results Program, , Division of Cancer Control and Population Sciences, National Cancer Institute, All Sites Breast (female) Colon Esophagus Leukemia Non-Hodgkin lymphoma Oral cavity Prostate Rectum Urinary bladder Uterine cervix74668 Uterine corpus Site White Difference African American

Trends in Incidence Rates by Tumor & Race, US, to Source: Surveillance, Epidemiology, and End Results Program, , Division of Cancer Control and Population Science, National Cancer Institute, White All races African American

Source: Surveillance, Epidemiology, and End Results Program, , Division of Cancer Control and Population Science, National Cancer Institute, White All races African American Trends in Incidence Rates by Stage & Race, US, to

Source: Surveillance, Epidemiology, and End Results Program, , Division of Cancer Control and Population Science, National Cancer Institute, Female Breast Cancer, US,

STAGETUMOR SPREAD? 0carcinoma in situ (abnormal cells) NO Itumor < 2 cm NO IIA1) no tumor in breast but cancer in underarm lymph YES nodes only 2) tumor < 2 cm & spread to underarm lymph nodes YES only 3) tumor > 2 cm but < 5 cm NO IIB1) tumor > 2 cm but < 5 cm & spread to underarm YES lymph nodes only 2) tumor > 5 cm NO Stages of Female Breast Cancer Source: National Cancer Institute, 2005.

STAGETUMOR SPREAD? IIIA1) no tumor but has spread to underarm lymph nodes YES & are attached to each other or other structures 2) tumor < 5 cm and spread to underarm lymph nodes YES & are attached to each other or other structures 3) tumor > 5 cm and spread to underarm lymph nodes YES & may be attached to each other or other structures IIIBAny size tumor and spread to other tissues near the YES breast and may have spread to the underarm lymph nodes IIICCancer has spread to the lymph nodes near the neck YES and under the collarbone. (May be operable or inoperable) IVCancer has spread to other organs YES Stages of Female Breast Cancer Source: National Cancer Institute, 2005.

Objectives Choose to receive treatments for breast cancer Decision Maintain quality of life Five year survival Able to care For oneself Fundamental Objectives Means Objectives Able to work go places with family

Influence Diagram Diagnosed with breast cancer Receive treatments? Diagnose stage of breast cancer Remission Death

Pre-cancerous cells only Surgery Radiation Chemotherapy May have to have this treatment = Stage 0 Treatment Influence Diagram

Stage I Treatment Influence Diagram Tumor < 2 cm 92% Stage I May have to have this treatment = Surgery Radiation Chemotherapy

Stage II Treatment Influence Diagram Tumor < 2 cm 92% Surgery, Radiation & Chemotherapy 2 cm <Tumor < 5 cm 77% Tumor > 5 cm 55% Lymphnodes Lymph nodesunderarm Stage IIA Stage IIB Stage IIA Stage IIB

Stage III Treatment Influence Diagram Tumor > 5 cm 55% Lymph nodes underarm attached to each other Surgery, Radiation & Chemotherapy Stage IIIA Tumor < 5 cm Stage IIIA Other tissues Stage IIIB Lymph nodes other than underarm Stage IIIC May also have this condition = Stage IIIB

Stage IV Treatment Influence Diagram Surgery, Radiation & Chemotherapy Spread to other organs in the body

Planning the Decision Tree  Decisions  Receive treatments or not  Uncertain events  Stage of breast cancer  Survival vs. death  Objectives  Maintain quality of life  Five year survival

Decision Tree Diagnosed with breast cancer. Choose to receive treatment or not? Survival Death CONTINUED… 0 6 EMV = 5 EMV = 1.84 EMV= 2.16 EMV= 0.20 EMV= 1.08 EMV = 2.43 EMV= % 37% 27% 11% 5% Receive treatments Don’t receive treatments Stage 0 Stage I Stage II Stage III Stage IV 1% 99% “Values” assigned to each outcome: 6 = survival with no treatment 5 = surgery 4 = chemotherapy 3 = surgery & radiation 2 = surgery & chemotherapy 1 = surgery, radiation & chemotherapy 0 = death

Stage 0 Branch of Decision Tree 1 Lumpectomy 2 Lumpectomy with radiation 3 Total mastectomy Survival Death Survival Death Survival Death Survival 100% 0% 1% 99% EMV = 0.06 EMV = 5 EMV 1 = 5 EMV 3 = 5 EMV 2 = 4 EMV = 5 Receive treatments Don’t receive treatments Stage 0

Stage I Branch of Decision Tree 1 Lumpectomy with removal of some lymph nodes with radiation & adjuvant therapy 2 Mastectomy with removal of some lymph nodes with radiation & adjuvant therapy Survival Death Survival Death Survival % 8% 1% 99% EMV 1 = 1.84 EMV 2 = 1.84 EMV = 0.06 EMV = 1.84 Stage I Receive treatments Don’t receive treatments EMV = 1.84

Stage II Branch of Decision Tree 1 Lumpectomy with removal of some lymph nodes with radiation & adjuvant therapy 2 Mastectomy with removal of some lymph nodes with radiation & adjuvant therapy Survival Death Stage IIA Stage IIB 1 Lumpectomy with removal of some lymph nodes with radiation & adjuvant therapy 2 Mastectomy with removal of some lymph nodes with radiation & adjuvant therapy Death Survival Death Survival Death Survival Death Survival 92% 81% 8% 19% 1% 99% EMV 1 = 1.62 EMV 2 = 1.62 EMV = 0.06 EMV 1 = 1.84 EMV 2 = 1.84 EMV= 1.62 EMV= 1.84 Stage II Receive treatments Don’t receive treatments

Stage III Branch of Decision Tree 1 Modified radical mastectomy with radiation & adjuvant therapy 2 Chemotherapy then lumpectomy with radiation & adjuvant therapy Survival Death Stage IIIA Stage IIIB Death Survival Death Survival Death Survival Death Survival Stage IIIC 1 2 Death Survival Death Survival 1 Operable - modified radical mastectomy with radiation & adjuvant therapy 2 Inoperable – systemic chemotherapy, surgery and radiation 2 Systemic chemotherapy, surgery and radiation 1 Systemic chemotherapy 67% 54% 46% 33% 1% 99% ?% EMV 1 = 1.34 EMV 2 = 1.34 EMV= 1.34 EMV 1 = 2.16 EMV 2 = 2.16 EMV= 2.16 EMV 1 = ? >0 EMV 2 = ? >0 EMV= ? >0 EMV= 0.06 EMV= 2.16 Receive treatments Don’t receive treatments Stage III

Stage IV Branch of Decision Tree Survival Death Treatment can be done to lengthen and maintain quality of life. 100% 0% 0 6 Survival Death 80% 20% 0 1 EMV= 0.06 EMV = 0.20 Receive treatments Don’t receive treatments Stage IV

Conclusion: DECISION ASSUMPTIONS: WhiteWhite WomanWoman Age yearsAge years If diagnosed in the next 5 years, the decision would be to receive treatments with an EMV = No matter what stage of cancer the testing reveals, still choose to receive treatments.

Bibliography 1. National Center for Health Statistics, Centers for Disease Control and Prevention, US Mortality Public Use Data Tape American Cancer Society (2004). Cancer Facts & Figures Retrieved November 1, 2005, from American Cancer Society website: American Cancer Society (2005). Breast Cancer Facts & Figures Retrieved November 1, 2005, from American Cancer Society website: American Cancer Society (2005). Cancer Reference Information. Retrieved November 1, 2005, from American Cancer Society website: taging_5.asp?sitearea taging_5.asp?sitearea 5. National Cancer Institute (2005). Breast Cancer: Treatment. Retrieved November 1, 2005, from the National Cancer Institute website: 6. The Susan G. Komen Breast Cancer Foundation ( ). Retrieved November 1, 2005 from the Susan G. Komen Breast Cancer Foundation website:

7. National Cancer Institute (2005). SEER Stat Fact Sheets. Retrieved November 1, 2005 from the National Cancer Institute website: ml&x=15&y=13 ml&x=15&y=13 8. Kamenova, B.S, Sanmugarajah J. and Solomon, W. (2005). Tumor size and stage distribution among the newly diagnosed breast cancer patients in an inner-city hospital in Brooklyn. Journal of Clinical Oncology, V 23, No. 16S (June 1 Supplement). Retrieved from Journal of Clinical Oncology website: Center for Disease Control and Prevention (2005). Retrieved from CDC website: “2004 Cancer Committee Annual Report” released Oct Retrieved from Washington Hospital website: 20Committee%20Annual%20Report.pdf 20Committee%20Annual%20Report.pdfBibliography